CERETAG 60MG contains Cerebroprotein Hydrolysate which belongs to the group of medicines called Neurotrophic agents. It is used to treat cranial injury (trauma to scalp, skull, and/or brain), inability to sustain concentration in dementia (group of disease or illness that affects your ability to think, memorize and reason), cerebrovascular disease that includes stroke (brain damage due to interruption of blood flow), and alzheimer's disease (progressive neurologic disorder that causes brain to shrink and brain cells to die).
Cerebroprotein hydrolysate is a neurotrophic agent which works by protecting the nerve cells from toxins and lack of oxygen thus improving its survival rate. It also helps in the formation of new nerve cells by increasing nutrition supply to the brain cells and reducing the inflammatory reaction of the brain tissues which results in preventing damage to the brain cells.
CERETAG 60MG is not recommended for use in patients with severe kidney dysfunction, status epilepticus (life threatening neurological disorder), and or major epilepsia (seizure that causes loss of consciousness). It should be used with caution in patients with epilepsy (fits or seizures) and or allergic diathesis (condition that causes group of allergic reaction such as hay fever, allergic rhinitis, bronchial asthma, or atopic dermatitis).
CERETAG 60MG should be used with caution in pregnant and breastfeeding women only if it is clearly advised by your doctor. It should be used with caution in elderly patients (above 65 years). Consult your doctor before receiving. The common side effects associated with the use of CERETAG 60MG are headache, nausea, vertigo (sensation of spinning), increased sweating, agitation, fever, and hallucinations. Inform your doctor if any of the symptom worsens.
It is used to treat:
CERETAG 60MG helps in restoring brain functions, where cerebroprotein hydrolysate works by protecting the nerve cells from toxins and lack of oxygen thus improving its survival rate. It also helps in the formation of new nerve cells by increasing nutrition supply to the brain cells and reducing the inflammatory reaction on the brain tissues which results in preventing damage to the brain cells.
CERETAG 60MG will be given to you only by a doctor or a nurse into the vein. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Consult your doctor if you experience any of the following side effects:
Headache:
Take rest and drink plenty of water. Do not strain your eyes by watching screen for long time. Inform your doctor if the condition persists for long or gets worsened.
Diarrhoea:
Drink lot of fluids, such as water to keep yourself hydrated, consult your doctor if the symptom gets worse.
Constipation:
Try to eat more high-fibre foods such as fresh fruit, vegetables, cereals, and drink plenty of water. If this does not help, inform your doctor for receiving alternate treatments for constipation.
Nausea and vomiting:
Eat light and bland foods. Avoid eating foods which are hard to digest and eat less when you feel nauseated. Drink clear or ice-cold drinks. Rest after eating with the head elevated. Consult your doctor if the symptom gets worse.
CERETAG 60MG should be used cautiously in pregnant women only if it is considered clearly necessary. Consult your doctor before receiving CERETAG 60MG.
CERETAG 60MG should be used cautiously in breastfeeding women only if it is considered clearly necessary. Consult your doctor before receiving CERETAG 60MG.
Do not drive or operate machines after receiving CERETAG 60MG to avoid any possible risk. Consult your doctor before receiving CERETAG 60MG.
Consult your doctor before receiving CERETAG 60MG if you consumed alcohol recently.
CERETAG 60MG is not recommended for use in patients with severe kidney dysfunction. It should be used with caution in patients with other kidney problems. Consult your doctor before receiving CERETAG 60MG.
CERETAG 60MG should be used with caution in patients with liver disease. Consult your doctor before receiving CERETAG 60MG.
Do not receive CERETAG 60MG if you are allergic to cerebroprotein hydrolysate or any other ingredients of this medicine. Consult your doctor before receiving.
CERETAG 60MG is not recommended for use if you have:
Before receiving CERETAG 60MG, inform your doctor if you have:
Use in Paediatrics:
CERETAG 60MG should be used with caution in children. Consult child’s doctor before receiving CERETAG 60MG.
Use in Geriatrics
CERETAG 60MG should be used with caution in elderly patients (aged 65 years and above). Consult your doctor before receiving CERETAG 60MG.
A. Drug-Drug Interactions
Before receiving CERETAG 60MG, inform your doctor, if you are taking any of the following medicine:
Overdosage:
CERETAG 60MG will be given to you only by a doctor or nurse in a hospital setting, and so it is unlikely to receive an overdose. However, if you experience any unusual symptoms, consult your doctor immediately.
Drug | : | Cerebroprotein hydrolysate |
Pharmacological Category | : | Neurotrophic agents |
Therapeutic Indication | : | Cranial injury, Aprosexia (inability to concentrate) in dementia, Cerebrovascular disease including stroke, Alzheimer's disease |
Dosage Forms | : | Tablet, Injection |
What is CERETAG 60MG used for?
CERETAG 60MG contains Cerebroprotein hydrolysate (that belongs to group of medicines called neurotrophic agents) which is used to treat cranial injury, aprosexia (inability to concentrate) in dementia, stroke (lack of blood supply in the brain), and alzheimer's disease (disease caused due to degeneration of brain cells) in affected individuals.
What side effects are seen with CERETAG 60MG?
The common side effects associated with the use of CERETAG 60MG are headache, nausea, vertigo (sensation of spinning), increased sweating, agitation, fever, and hallucinations. Inform your doctor if any of the symptom worsens.
Who should avoid receiving CERETAG 60MG?
CERETAG 60MG is not recommended for use in patients who are allergic to cerebroprotein hydrolysate, and in patients suffering from severe kidney dysfunction, status epilepticus (life threatening neurological disorder), or major epilepsia (seizure that causes loss of consciousness and violent muscle contractions). Consult your doctor before receiving CERETAG 60MG.
Is CERETAG 60MG safe to use in elderly patients?
CERETAG 60MG should be used with caution in elderly patients (aged 65 years and above) especially those who do not respond to anticholinesterases (such as neostigmine or pyridostigmine). Consult your doctor before receiving CERETAG 60MG.
How does CERETAG 60MG work?
CERETAG 60MG helps in restoring brain functions where cerebroprotein hydrolysate works by protecting the nerve cells from toxins and lack of oxygen thus improving its survival rate. It also helps in the formation of new nerve cells by increasing nutrition supply to the brain cells and reducing the inflammatory reaction on the brain tissues which results in preventing damage to the brain cells.
What is method of receiving CERETAG 60MG?
CERETAG 60MG will be given to you only by a doctor or a nurse into the vein. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Can CERETAG 60MG cause flu?
Yes, CERETAG 60MG may cause flu like symptoms such as fever, chills, sore throat, and cough in some patients which is generally temporary and resolves with time. However, inform your doctor if the symptom worsens over the time.
Is CERETAG 60MG safe to use in patients with kidney problems?
CERETAG 60MG is not recommended for use in patients with severe kidney dysfunction. It should be used with caution in patients with other kidney problems. Consult your doctor before receiving CERETAG 60MG.
1. Perry B. Molinoff. Neurotransmission and the Central Nervous System. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. Twelfth Edition. 2011. Page – 375.
2. Mosam Phirke, Avinash Desousa, Nilesh Shah, Sushma Sonavane, Anup Bharati. The use of cerebroprotein hydrolysate in dementia: A case series of 25 cases seen in a tertiary general hospital. Journal of geriatric mental health. 2014. [Accessed on 7th July 2022] https://www.jgmh.org/article.asp?issn=2348-9995;year=2014;volume=1;issue=2;spage=106;epage=109;aulast=Phirke
3. Fanbing Kong, Hujie Song. Progress in Treatment of Spastic Cerebral Palsy with Integrated Traditional Chinese and Western Medicine. Clausius Scientific Press. MEDS Clinical Medicine. 2021. [Accessed on 7th July 2022] http://clausiuspress.com/assets/default/article/2021/11/24/article_1637736393.pdf
4. Ciplamed. Cerebrocip Injection (Cerebroprotein hydrolysate). [Revised in August 2017] [Accessed on 7th July 2022] https://www.ciplamed.com/content/cerebrocip-injection
5. Medicrit Biotech Private Limited. Cerbocin 60 mg Injection. [Accessed on 7th July 2022] https://www.medicrit.co.in/product/cerbocin-60mg-injection/
Additional Discount on this product
Please get a call back from our expert
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.